Marinus Pharmaceuticals | MRNS - Stock


Marinus Pharmaceuticals reported $4.87M in Stock for its fiscal quarter ending in June of 2024.



Stock Change Date
Acadia Pharmaceuticals USD 34.67M 5.57M Dec/2025
ALKERMES USD 196.62M 5.63M Dec/2025
Amgen USD 6.22B 121M Dec/2025
Biogen USD 2.17B 41.3M Dec/2025
Eisai JPY 236.46B 9.14B Sep/2025
Esperion Therapeutics USD 108.54M 5.93M Sep/2025
Gilead Sciences USD 1.78B 40M Sep/2025
Incyte USD 101.06M 17.61M Dec/2025
Neurocrine Biosciences USD 69M 300K Dec/2025
PTC Therapeutics USD 79.65M 26.96M Dec/2025
Regeneron Pharmaceuticals USD 3.2B 53.6M Dec/2025
Sarepta Therapeutics USD 914.74M 162.42M Dec/2025
Supernus Pharmaceuticals USD 107.1M 63.08M Sep/2025
UCB EUR 1.31B 173M Dec/2024
Vertex Pharmaceuticals USD 1.69B 60M Dec/2025